ImageneBio, Inc.
IMA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
Business Summary
1 Item 1A. Risk Factors 36 Item 1B. Unresolved Staff Comments 93 Item 1C. Cybersecurity 93 Item 2. Properties 94 Item 3. Legal Proceedings 95 Item 4. Mine Safety Disclosures 95 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 96 Item 6. [Reserved] 96 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 97 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 107 Item 8...
Next Earnings
Q2 FY2026 — expected 2026-08-19
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | IMA | discussed_in_filing Cybersecurity | |
| topic_mention | IMA | discussed_in_filing Cybersecurity | |
| topic_mention | IMA | discussed_in_filing Cybersecurity | |
| topic_mention | IMA | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-10 | 2025-12-31 | 0001193125-26-099434 | EDGAR | 101K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034188 | EDGAR | — |
| 2024-03-12 | 2023-12-31 | 0000950170-24-029651 | EDGAR | — |
| 2023-03-14 | 2022-12-31 | 0000950170-23-007681 | EDGAR | — |
| 2022-03-17 | 2021-12-31 | 0000950170-22-003998 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-275932 | EDGAR | 74K words |
| 2025-07-24 | 2025-06-30 | 0000950170-25-098414 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066411 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122818 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093880 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058715 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061535 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-040943 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021909 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022323 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016600 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0000950170-22-009446 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-17 | 0001193125-26-110945 | EDGAR | 1K words |
| 2026-03-10 | 0001193125-26-099422 | EDGAR | — |
| 2026-02-17 | 0001193125-26-054684 | EDGAR | — |
| 2025-12-18 | 0001193125-25-324798 | EDGAR | — |
| 2025-11-19 | 0001193125-25-286984 | EDGAR | — |
| 2025-11-12 | 0001193125-25-275910 | EDGAR | — |
| 2025-11-05 | 0001193125-25-266889 | EDGAR | — |
| 2025-10-29 | 0001193125-25-254697 | EDGAR | — |
| 2025-10-22 | 0001193125-25-245823 | EDGAR | — |
| 2025-10-10 | 0001193125-25-237161 | EDGAR | — |
79 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001835579 |
| Ticker | IMA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 408e1f6a9f23dca8c1cd2746dcd23ed03d25345a28a11268215f95cea1959967
parent: da7a35ddac5d08de84484fc17825ff7b3d477d7bcf1697628d45910e1df8cd2a
content hash: 2099992f40f41b062a7354251e3ed34eb6437d144f9d3efe3c2dc6388449e609
signed: 2026-04-13T04:45:40.109Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf